What Doctors thought of this year’s ESMO Event
Reaching European attendees, our 2023 Post-ESMO report sought to understand the event’s areas of greatest interest. 95 European oncologists and haematologist-oncologists shared with us the findings and developments they found most exciting.
Learn what respondents thought of the latest advancements including NSCLC, breast cancer, and Urothelial cancer treatments.
Download the report today.